These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 23709655

  • 1. Sex hormone binding globulin and sex steroids among premenopausal women in the diabetes prevention program.
    Kim C, Pi-Sunyer X, Barrett-Connor E, Stentz FB, Murphy MB, Kong S, Nan B, Kitabchi AE, Diabetes Prevention Program Research Group.
    J Clin Endocrinol Metab; 2013 Jul; 98(7):3049-57. PubMed ID: 23709655
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program.
    Golden SH, Kim C, Barrett-Connor E, Nan B, Kong S, Goldberg R, Diabetes Prevention Program Research Group.
    Metabolism; 2013 Sep; 62(9):1313-22. PubMed ID: 23660512
    [Abstract] [Full Text] [Related]

  • 4. Endogenous sex hormone changes in postmenopausal women in the diabetes prevention program.
    Kim C, Kong S, Laughlin GA, Golden SH, Mather KJ, Nan B, Edelstein SL, Randolph JF, Labrie F, Buschur E, Barrett-Connor E.
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2853-61. PubMed ID: 22689695
    [Abstract] [Full Text] [Related]

  • 5. Does hormone therapy affect blood pressure changes in the Diabetes Prevention Program?
    Kim C, Golden SH, Kong S, Nan B, Mather KJ, Barrett-Connor E, Diabetes Prevention Program Research Group.
    Menopause; 2014 May; 21(5):477-83. PubMed ID: 23942251
    [Abstract] [Full Text] [Related]

  • 6. Reductions in glucose among postmenopausal women who use and do not use estrogen therapy.
    Kim C, Kong S, Laughlin GA, Golden SH, Mather KJ, Nan B, Randolph JF, Edelstein SL, Labrie F, Buschur E, Barrett-Connor E, Diabetes Prevention Program Research Group.
    Menopause; 2013 Apr; 20(4):393-400. PubMed ID: 23168523
    [Abstract] [Full Text] [Related]

  • 7. Changes in Visceral Adiposity, Subcutaneous Adiposity, and Sex Hormones in the Diabetes Prevention Program.
    Kim C, Dabelea D, Kalyani RR, Christophi CA, Bray GA, Pi-Sunyer X, Darwin CH, Yalamanchi S, Barrett-Connor E, Golden SH, Boyko EJ.
    J Clin Endocrinol Metab; 2017 Sep 01; 102(9):3381-3389. PubMed ID: 28651370
    [Abstract] [Full Text] [Related]

  • 8. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug 01; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 9. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AM.
    Metabolism; 1997 Jan 01; 46(1):5-9. PubMed ID: 9005961
    [Abstract] [Full Text] [Related]

  • 10. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status.
    Randolph JF, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, McConnell DS, Finkelstein JS, Korenman SG, Matthews KA, Sternfeld B, Lasley BL.
    J Clin Endocrinol Metab; 2003 Apr 01; 88(4):1516-22. PubMed ID: 12679432
    [Abstract] [Full Text] [Related]

  • 11. Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program.
    Aroda VR, Christophi CA, Edelstein SL, Perreault L, Kim C, Golden SH, Horton E, Mather KJ, DPP Research Group.
    BMJ Open Diabetes Res Care; 2020 Dec 01; 8(2):. PubMed ID: 33328161
    [Abstract] [Full Text] [Related]

  • 12. Weight loss increases follicle stimulating hormone in overweight postmenopausal women [corrected].
    Kim C, Randolph JF, Golden SH, Labrie F, Kong S, Nan B, Barrett-Connor E.
    Obesity (Silver Spring); 2015 Jan 01; 23(1):228-33. PubMed ID: 25294746
    [Abstract] [Full Text] [Related]

  • 13. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN).
    Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, Pasternak RC, Lloyd-Jones D, Sowers MF, Torréns JI, SWAN Investigators.
    Circulation; 2005 Mar 15; 111(10):1242-9. PubMed ID: 15769764
    [Abstract] [Full Text] [Related]

  • 14. Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.
    Kim C, Christophi CA, Goldberg RB, Perreault L, Dabelea D, Marcovina SM, Pi-Sunyer X, Barrett-Connor E.
    Diabet Med; 2016 Jan 15; 33(1):32-8. PubMed ID: 25970741
    [Abstract] [Full Text] [Related]

  • 15. Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program.
    West DS, Elaine Prewitt T, Bursac Z, Felix HC.
    Obesity (Silver Spring); 2008 Jun 15; 16(6):1413-20. PubMed ID: 18421273
    [Abstract] [Full Text] [Related]

  • 16. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.
    Crave JC, Fimbel S, Lejeune H, Cugnardey N, Déchaud H, Pugeat M.
    J Clin Endocrinol Metab; 1995 Jul 15; 80(7):2057-62. PubMed ID: 7608255
    [Abstract] [Full Text] [Related]

  • 17. Sex hormone-binding globulin and risk of clinical diabetes in American black, Hispanic, and Asian/Pacific Islander postmenopausal women.
    Chen BH, Brennan K, Goto A, Song Y, Aziz N, You NC, Wellons MF, Manson JE, White DL, Butch AW, Liu S.
    Clin Chem; 2012 Oct 15; 58(10):1457-66. PubMed ID: 22908136
    [Abstract] [Full Text] [Related]

  • 18. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
    Ye BL, Yang HY, Zhao JZ, Lin JJ, Lin WQ.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec 15; 38(12):745-8. PubMed ID: 14728846
    [Abstract] [Full Text] [Related]

  • 19. Testosterone and depressive symptoms among men in the Diabetes Prevention Program.
    Kim C, Barrett-Connor E, Aroda VR, Mather KJ, Christophi CA, Horton ES, Pi-Sunyer X, Bray GA, Labrie F, Golden SH, Diabetes Prevention Program Research Group.
    Psychoneuroendocrinology; 2016 Oct 15; 72():63-71. PubMed ID: 27371769
    [Abstract] [Full Text] [Related]

  • 20. Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males.
    Lopez DS, Peskoe SB, Joshu CE, Dobs A, Feinleib M, Kanarek N, Nelson WG, Selvin E, Rohrmann S, Platz EA.
    Cancer Causes Control; 2013 Apr 15; 24(4):817-26. PubMed ID: 23354421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.